Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.
Isabel Gómez-HurtadoPaula GimenezIrma GarcíaPedro ZapaterRubén FrancésJosé M González-NavajasChaysavanh ManichanhJosé M RamosPablo BellotFrancisco GuarnerJosé SuchPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Norfloxacin is more effective than Rifaximin in preventing bacterial translocation in rats with cirrhosis probably because of its capacity to reduce pathobionts from intestinal microbiota.
Keyphrases